World's Best Scientists 2026 revealed!
Jean-Michel Dayer

Jean-Michel Dayer

D-Index & Metrics

Immunology

D-Index
91
Citations
33818
World Ranking
1028
National Ranking
26

Medicine

D-Index
92
Citations
34766
World Ranking
11211
National Ranking
151

Overview

Jean-Michel Dayer is affiliated with the University of Geneva in Switzerland. Their research primarily spans the field of Medicine, with a focus on various subfields including Rheumatology, Pathology and Forensic Medicine, Immunology, Nephrology, and Complementary and Manual Therapy.

The main topics covered in their work include:

  • Systemic Lupus Erythematosus Research
  • Systemic Sclerosis and Related Diseases
  • T-cell and B-cell Immunology
  • Gout, Hyperuricemia, Uric Acid
  • Therapeutic Uses of Natural Elements
  • Case Reports on Hematomas

Recent publications by Jean-Michel Dayer reflect research in these areas. Two notable papers are:

  • Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment, 2021, Frontiers in Pharmacology
  • Effect of pathogenic crystals on the production of pro- and anti-inflammatory cytokines by different leukocyte populations, 2020, Immunobiology

The researcher frequently collaborates with others in the field. Frequent coauthors include:

  • François Chasset
  • Carlo Chizzolini
  • Anna Scanu
  • Francesca Oliviero
  • Roberto Luisetto

Jean-Michel Dayer's work has been published in venues such as Frontiers in Pharmacology and Immunobiology. Their publications contribute to ongoing research in immunological and rheumatological diseases, with an emphasis on molecular and clinical insights into autoimmune and inflammatory conditions.

Best Publications

  • Effect of Mechanical Ventilation on Inflammatory Mediators in Patients with Acute Respiratory Distress Syndrome: A Randomized Controlled Trial

    V. Marco Ranieri;Peter M. Suter;Cosimo Tortorella;Renato De Tullio

  • Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.

    J M Dayer;B Beutler;A Cerami

  • Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritis

    William P. Arend;Jean‐Michel Dayer

  • Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.

    Véronique Witko-Sarsat;Miriam Friedlander;Thao Nguyen Khoa;Chantal Capeillère-Blandin

  • CCR5 is characteristic of Th1 lymphocytes

    Pius Loetscher;Mariagrazia Uguccioni;Lorenza Bordoli;Marco Baggiolini

  • Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.

    Eric Girardin;Georges E. Grau;Jean-Michel Dayer;Pascale Roux-Lombard

  • Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells.

    J M Dayer;B de Rochemonteix;B Burrus;S Demczuk

  • Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte- activating factor (interleukin 1)

    Steven B. Mizel;Jean-Michel Dayer;Stephen M. Krane;Stephan E. Mergenhagen

  • High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis.

    Peter M. Suter;Susanne Suter;Eric Girardin;Pascale Roux-Lombard

  • Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells

    J M Dayer;S M Krane;R G Russell;D R Robinson

  • IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes.

    S Lacraz;L P Nicod;R Chicheportiche;H G Welgus

  • Leflunomide: mode of action in the treatment of rheumatoid arthritis

    F C Breedveld;J M Dayer

  • Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.

    Jean-Dominique Vassalli;Jean-Michel Dayer;Annelise Isabelle Wohlwend;Dominique Belin

  • Apolipoprotein A-I inhibits the production of interleukin-1β and tumor necrosis factor-α by blocking contact-mediated activation of monocytes by T lymphocytes

    Nevila Hyka;Jean-Michel Dayer;Christine Modoux;Tadahiko Kohno

  • Production of Chemokines by Perivascular Adipose Tissue: A Role in the Pathogenesis of Atherosclerosis?

    Elvire Henrichot;Cristiana E. Juge-Aubry;Agnès Pernin;Jean-Claude Pache

  • A urine inhibitor of interleukin 1 activity that blocks ligand binding.

    P Seckinger;J W Lowenthal;K Williamson;J M Dayer

  • How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy

    Georg Schett;Dirk Elewaut;Iain B. McInnes;Jean-Michel Dayer

  • Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk

    Emma Borrelli;Pascale Roux-Lombard;Georges E. Grau;Eric Girardin

  • Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis.

    Martine Chabaud;Patrick Garnero;Jean-Michel Dayer;Pierre-André Guerne

  • Adipose Tissue Is a Major Source of Interleukin-1 Receptor Antagonist: Upregulation in Obesity and Inflammation

    Cristiana E. Juge-Aubry;Emmanuel Somm;Vittorio Giusti;Agnès Pernin

Frequent Co-Authors

Carlo Chizzolini
Carlo Chizzolini University of Geneva
Leonardo Punzi
Leonardo Punzi University of Padua
Cem Gabay
Cem Gabay University of Geneva
Jean-Hilaire Saurat
Jean-Hilaire Saurat University of Geneva
Barry Bresnihan
Barry Bresnihan University College Dublin
Howard G. Welgus
Howard G. Welgus Arcutis Biotherapeutics
Georges E. Grau
Georges E. Grau University of Sydney
Andrea Doria
Andrea Doria University of Padua
Oliver FitzGerald
Oliver FitzGerald University College Dublin
Bernard Mach
Bernard Mach University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, branching into healthcare roles such as nursing can provide valuable clinical insights and career opportunities. Many students may find it beneficial to explore programs with straightforward admission requirements. For example, easy admission LPN programs offer a quick pathway into practical nursing, making them accessible for a wide range of applicants.

Advancing further, becoming a Nurse Practitioner (NP) is a popular option, especially with programs that maintain flexible admissions. Those looking for options with less competitive entry might consider nurse practitioner programs with easy admission. These can provide specialized training relevant to immunology-focused patient care.

Specializing in mental health, the Psychiatric-Mental Health Nurse Practitioner (PMHNP) role combines immunology knowledge with behavioral health expertise. Many students seek the best PMHNP programs to ensure high-quality clinical placements, which are crucial for hands-on experience and career readiness.

Cost is often a deciding factor, especially for online options. Those looking to minimize expenses can find cheapest PMHNP programs online that still deliver comprehensive education and prepare graduates for certification and advanced practice roles.

Best Scientists Citing Jean-Michel Dayer

Trending Scientists